Quantcast

Latest rheumatoid arthritis Stories

2014-06-30 12:26:16

NORWALK, Conn., June 30, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network, a leading online community for Rheumatologists, offers special coverage of the major European rheumatology conference, just concluded in Paris, France. The annual meeting of the European Union League Against Rheumatism (EULAR) is one of the two major conferences at which rheumatologists share their latest research. Important news from this conference for the millions of people in the US with...

2014-06-28 12:09:52

St. Michael's Hospital More screening may be needed Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests. Current guidelines for what constitutes a positive TB skin test among corticosteroid pill users may not be capturing all those who are infected, said Dr. Nicholas Vozoris, a respirologist in the Tuberculosis Program at St. Michael's Hospital. Previous research has shown that people who take corticosteroid pills, such as...

2014-06-26 08:28:32

NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated--struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change that by launching the largest...

2014-06-23 12:29:24

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter REDWOOD CITY, Calif., June 23, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar, in rheumatoid arthritis (RA). The Phase 3 trial is a randomized, double-blind, active-control, parallel-group, multicenter, global study in subjects with active RA who have demonstrated an inadequate response to methotrexate....

2014-06-19 23:14:24

As Arthritis Action Month drew to a close in May, the Arthritis Foundations and United States Center for Disease Control brought to the forefront the importance of becoming educated on arthritis and other rheumatic conditions (or AORC) and arthritis related care issues, as presented in this infographic from EntraCell. Los Angeles, CA (PRWEB) June 19, 2014 One in two adults, 65 years and older, suffer through arthritis pain. Managing pain is a harsh reality when growing older, so any...

2014-06-16 13:03:46

University of Melbourne New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne-lead study successfully mapped the genes of a parasitic worm in pigs New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped the genes of a...

2014-06-12 00:22:01

Both doses of investigational drug sarilumab met all three co-primary endpoints PARIS and TARRYTOWN, N.Y., June 12, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today presented positive results from a phase 3 trial of investigational drug sarilumab in rheumatoid arthritis (RA) patients who were inadequate responders to methotrexate (MTX) therapy. New data presented at the meeting showed that sarilumab increased major clinical...

2014-06-11 04:21:56

- Findings Show Positive Association Between Adherence and Anti-TNF Therapy Compared to Conventional Therapy PARIS, June 11, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases (IMIDs), adherence to treatment was generally higher in patients being treated with TNF inhibitors compared to patients treated with conventional therapy. Furthermore, patients who were...

2014-06-10 23:13:54

Achieve is conducting a multicenter, randomized, single-dose study assessing the pharmacodynamic parameters of an experimental combination therapy in patients with rheumatoid arthritis on stable methotrexate (MTX) treatment. Birmingham, AL (PRWEB) June 10, 2014 *To see if you qualify for this RA Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance...

2014-06-04 08:31:12

New oral XELJANZ( TM), now available in Canada KIRKLAND, QC, June 4, 2014 /CNW/ - Catherine Hofstetter was diagnosed with rheumatoid arthritis 22 years ago and it changed her life. "My diagnosis felt like a life sentence," says Hofstetter. "Even though I was able to find a treatment to help me manage my symptoms, small, everyday things like buttoning a shirt can still be difficult. New treatments are essential in bringing hope to patients that their disease can be managed."...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related